Hepatocellular carcinoma in Navarre: study of characteristics and evolution in clinical practice

被引:0
作者
Elizalde Apestegui, I. R. [1 ,3 ]
Saldana Duenas, C. [1 ]
Goni Esarte, S. [1 ]
Prieto Martinez, C. [1 ,3 ]
Sangro Gomez-Acebo, B. [2 ,3 ]
Zozaya Urmeneta, J. M. [1 ,3 ]
机构
[1] Complejo Hosp Navarra, Serv Aparato Digest, C Irunlarrea 3, Pamplona 31008, Spain
[2] Univ Navarra Clin, Pamplona, Spain
[3] Inst Invest Sanitaria Navarra IdISNA, Pamplona, Spain
关键词
Hepatocellular carcinoma; Epidemiology; Screening; RANDOMIZED CONTROLLED-TRIAL; LIVER-CANCER INCIDENCE; INTERNATIONAL TRENDS; UNITED-STATES; SURVEILLANCE; SURVIVAL;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Hepatocellular carcinoma generally arises in a cirrhotic liver. The aim of screening is to improve survival. The aims of our study are to determine the characteristics and evolution of hepatocellular carcinoma and the effect of screening on survival, in clinical practice in Navarre. Methods. Prospective and retrospective study of 111 patients diagnosed with hepatocellular carcinoma in public hospitals in Navarre between January 2009 and January 2015. Epidemiological, clinical, analytical, radiological characteristics, tumour staging, treatment and evolution were analyzed. Survival was compared between patients subjected to screening and those not. Results. Mean age was 67 years. The patients (84.7%) were mainly male and 85.6% had cirrhosis. The most frequent aetiology was alcohol consumption (40.7%). 62.2% were diagnosed in early stages, 15.3% in intermediate and 22.5 % in advanced or terminal stages. 4.5% received transplants, 21.6% received surgical resection, 23.4% were treated with ablation techniques, 10.8 % with chemoembolization, 5.4% with radiembolization, 2.7% with embolization, 13.5 % with sorafenib and 18% symptomatically. Only 32 patients (28.8%) were subjected to screening. No statistical differences were found in survival depending on surveillance (32 month versus 34; p = 0.971). Conclusions. In Navarre, hepatocellular carcinoma generally appears against a background of cirrhosis, and alcohol is the most frequent aetiology. Hepatocellular carcinoma is diagnosed most frequently in early stages and out of screening practices. Screening was not associated to better survival.
引用
收藏
页码:249 / 260
页数:12
相关论文
共 26 条
[1]   Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].
Altekruse, Sean F. ;
McGlynn, Katherine A. ;
Reichman, Marsha E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491
[2]  
BEASLEY RP, 1981, LANCET, V2, P1129
[3]   Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis [J].
Bolondi, L ;
Sofia, S ;
Siringo, S ;
Gaiani, S ;
Casali, A ;
Zironi, G ;
Piscaglia, F ;
Gramantieri, L ;
Zanetti, M ;
Sherman, M .
GUT, 2001, 48 (02) :251-259
[4]   Primary liver cancer:: Worldwide incidence and trends [J].
Bosch, FX ;
Ribes, J ;
Díaz, M ;
Cléries, R .
GASTROENTEROLOGY, 2004, 127 (05) :S5-S16
[5]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[6]   Hepatocellular carcinoma: Trends of incidence and survival in Europe and the United States at the end of the 20th century [J].
Capocaccia, Riccardo ;
Sant, Milena ;
Berrino, Franco ;
Simonetti, Arianna ;
Santi, Valentina ;
Trevisani, Franco .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (08) :1661-1670
[7]   International Trends in Liver Cancer Incidence Rates [J].
Center, Melissa M. ;
Jemal, Ahmedin .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (11) :2362-2368
[8]   Screening for liver cancer: results of a randomised controlled trial in Qidong, China [J].
Chen, JG ;
Parkin, DM ;
Chen, QG ;
Lu, JH ;
Shen, QJ ;
Zhang, BC ;
Zhu, YR .
JOURNAL OF MEDICAL SCREENING, 2003, 10 (04) :204-209
[9]   HEPATOCELLULAR-CARCINOMA IN ITALIAN PATIENTS WITH CIRRHOSIS [J].
COLOMBO, M ;
DEFRANCHIS, R ;
DELNINNO, E ;
SANGIOVANNI, A ;
DEFAZIO, C ;
TOMMASINI, M ;
DONATO, MF ;
PIVA, A ;
DICARLO, V ;
DIOGUARDI, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (10) :675-680
[10]  
European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI [10.1016/j.ejca.2011.12.021, 10.1016/j.jhep.2011.12.001]